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Background: Campylobacter concisus is an emerging enteric pathogen associated with prolonged diarrhoea
and possibly inflammatory bowel disease in children as well as adults, but the interaction with cells of the
innate immune system is unclear. The magnitude of systemic immunoglobulin response in acute infection
is unknown.
Methods: Neutrophils from healthy volunteers were activated with five faecal isolates of C. concisus from
patients with gastroenteritis as well as the oral reference strain C. concisus ATCC33237. Neutrophils were
tested for the expression of adherence molecule CD11b by immunoflourescence and for oxidative burst
response by chemiluminescence. The opsonic activity in a chemiluminescence assay was assessed with heat
treated serum from patients with C. concisus infection.
Results: A strong and dose-dependent activation of neutrophil adherence molecule CD11b and oxidative
burst response was demonstrated with all six C. concisus isolates. Bacteria opsonised in heat treated serum
induced an increased chemiluminescence response. Heat treated serum from patients with C. concisus
infection did not have a higher opsonic activity than heat treated serum from healthy volunteers.
Conclusion: C. concisus has the capability to activate the innate immune system by stimulating neutrophil
cells to increased adherence molecule expression and oxidative burst response, both crucial for acute
inflammation. In a chemiluminescence assay the opsonic activity of heat treated serum from patients was not
increased compared to heat treated control serum suggesting a weak systemic IgG response to infection.
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Mucosal inflammation associated with Campylobacter
jejuni/coli enteritis is well described and in vitro exami-
nations of C. jejuni/coli have documented activation of
neutrophil cells in various assays relevant for acute inflam-
mation [1-5]. Recently another species, Campylobacter
concisus, has been reported as an emerging enteric pathogen
of unclear potential for gastrointestinal disease. In patients
with prolonged diarrhoea [6] as well as inflammatory
bowel disease [7-9] C. concisus is associated with clinical
manifestations of mucosal inflammation. However, the
mechanisms of action are unknown and the magnitude of
host inflammatory response to the pathogen is not well
described. Our group previously documented that both
faecal and oral isolates of C. concisus exhibit the potential
to induce impairment of the intestinal barrier function by* Correspondence: henrik.nielsen@rn.dk
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reproduction in any medium, provided the orinducing apoptotic leaks [10]. Furthermore C. concisus
isolates have been shown to have the ability to attach to
and invade human intestinal epithelial cells and induce
cytokine production [11]. Proteins of C. concisus from
Crohn’s disease patients have been identified to be
immunoreactive [12] but further knowledge of the human
immune reaction towards C. concisus is limited.
Neutrophil cells are crucial part of the innate immune
system and responsible for immediate local inflammatory
responses. Initial and early response of the peripheral
blood neutrophil upon stimulation with soluble substances
including cytokines is the up-regulation of adherence
molecules. When neutrophils subsequently interact with
microorganisms, either by phagocytosis or by binding
soluble pathogen products at the membrane, an activation
of the oxidative metabolism takes place. This is part of the
host defence against the microorganisms but is at the
same time responsible for tissue changes and features of
inflammation. The aim of our study was to examine the
capability of clinical isolates of C concisus to activateal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 2 Dose-dependency of up-regulation of CD11b in
neutrophils from three different donors at the given ratio
of C. concisus to neutrophils compared to the expression
when cells were exposed to PBS
Donor 1 Ratio 0.75:1 Ratio 7.5:1 Ratio 75:1
1718 8.0 9.4 12.6
197540 6.1 8.5 13.6
ATCC 7.4 8.7 11.9
75775 7.1 6.9 10.4
119100 6.1 9.1 15.1
118452 8.4 11.9 18.0
Donor 2
1718 7.9 9.7 12.4
197540 7.0 9.2 12.6
ATCC 6.5 8.5 11.8
75775 6.1 8.9 12.7
119100 7.1 12.5 14.4
118452 7.7 9.8 12.8
Donor 3
1718 11.0 17.5 19.6
197540 6,7 15.2 18.7
ATCC 9,9 13.9 18.1
75775 8.3 16.0 19.5
119100 7.7 16.5 19.0
118452 10.6 16.7 18.9
Values are presented as median of three experiments.
Sørensen et al. Gut Pathogens 2013, 5:17 Page 2 of 7
http://www.gutpathogens.com/content/5/1/17neutrophil cells for pro-inflammatory functions reflecting
initial adherence to the endothelium and subsequent oxi-
dative burst response upon activation. Furthermore, we
tested the immunoglobulin-dependent opsonic capacity of
serum for magnifying the neutrophil response to bacterial
challenge and compared serum from patients with




Experiments of adherence molecule CD11b up-regulation
were carried out with neutrophil cells from three different
healthy donors. For all three donors a dose–response
pattern was shown towards each of the six isolates
investigated. A rapid up-regulation of CD11b occurred at
0.75 CFU/neutrophil (median ratio 8.0; range 7.9-11.0)
indicating a quick and substantial response in the early
stages of the neutrophil activation. The median CD11b
up-regulation ratios for the neutrophil reaction of the
three donors towards isolate 2010–1718 at the bacterial
concentrations 0.75, 7.5 and 75 bacteria/neutrophil cell
were 8.0 (range 7.9-11.0), 9.7 (range 9.4-17.5), and 12.6
(range 12.4-19.6) (Table 1). The three donors had similar
starting points (7737, 8405 and 8551 middle fluorescence
intensity), but one donor responded considerably more
than the other two when C. concisus was added (Table 2).
This could be caused by inter-personnel difference in the
CD11b up-regulation capability or possibly that the more
responsive donor has previously been exposed to C.
concisus.
Oxidative burst response of neutrophils opsonised with
pooled serum from healthy donors
Measurement of the oxidative burst response of neutrophils
from healthy donors towards C. concisus isolate 2010–1718
at concentrations between 0.75 and 500 CFU/neutrophil,
using luminol dependent chemiluminiscence, expressed as
ratios between the response towards C. concisus opsonised
with pooled heat-treated serum and the response of
unstimulated cells, showed a dose–response patternTable 1 Dose-dependency of neutrophil up-regulation of
CD11b at the given ratio of C. concisus to neutrophils
compared to the expression when cells were exposed to PBS
Isolate Ratio 0.75:1 Ratio 7.5:1 Ratio 75:1
1718 8.0 9.7 12.4
197540 6.7 9.2 13.5
ATCC 7.4 8.7 11.9
75775 7.1 8.9 12.7
119100 7.1 12.5 15.1
118452 8.4 11.9 18.0
Values are presented as median of three experiments.(Figure 1). Values presented are median ratios of 4
experiments. This finding reflected that neutrophil cells
did in fact react towards C. concisus, at first increasing the
response rapidly as bacterial concentration increased, but
as the concentration of C. concisus reached 75 CFU/
neutrophil, the increase in response waned to a lower
gradient that appeared to be constant.
Measurements of oxidative burst response were carried
out for neutrophils from 54 healthy donors exposed to C.
concisus isolate 2010–1718 opsonised with pooled heat-
treated serum as well as C. concisus alone and compared
with baseline neutrophil response in PBS mixed with
pooled heat-treated serum. The response of neutrophils
was highest when C. concisus was opsonised with pooled
heat-treated serum (median: 1110 luminescence intensity
units, 95% CI: 667–1553 luminescence intensity units).
Neutrophil cells exposed to C. concisus without opsonisation
in serum also react (median: 605 luminescence intensity
units, 95% CI: 306–904 luminescence intensity units,
p<0,001), but less aggressively than when bacteria are
opsonised with serum (p<0,001) (Figure 2) demonstrating
the contribution of immunoglobulin dependent opsonic
capacity in the neutrophil response to C. concisus.
Figure 1 Degree of luminescence intensity generated by the oxidative burst response of neutrophils from healthy adult donors
towards C. concisus isolate 2010–1718 opsonised with heat-treated pooled serum, in ratios ranging from 1:0.75 to 1:500 (neutrophils
to bacteria). Neutrophil concentration was held constant at 2×106 cells/ml as the bacterial concentration was increased. Results are presented as
mean values and ranges of 4 experiments performed in duplicates.
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Comparing the neutrophil reactions towards six different
isolates of C. concisus on different steps of the inflammatory
response demonstrated a similar pattern of response
towards all isolates. The median ratios of CD11b up-
regulation towards bacteria at a concentration of 75 CFU/
neutrophil compared to the reaction of unstimulated cells
in the range from 11.9 to 18.0, and the median ratios of
oxidative burst response of neutrophils towards the same
amount of bacteria compared to the reaction of unstimu-
lated cells ranges from 2.4 to 3.2 (Table 3).Figure 2 Degree of luminescence intensity generated by the
oxidative burst response of neutrophils from healthy adult
donors towards C. concisus isolate 2010–1718 in the ratio 1:75
(neutrophils to bacteria) opsonised with heat-treated pooled
serum (dark grey), compared to the response without serum
(light grey) and the response when no bacteria but only
neutrophils and serum are present (white). Results represent
mean values ± 2 standard deviations of 54 experiments performed
in duplicates.Oxidative burst response of neutrophils to C. concisus
opsonised with patient sera
When measuring the oxidative burst reaction of neutrophils
towards C. concisus opsonised with heat treated serum
from 40 C. concisus infected patients they did not generate
a larger response than healthy adult donors (data not
shown). Furthermore, the opsonic activity in heat treated
serum from patients with C. concisus infection remained
unchanged four weeks after the baseline visit (p=0.15).
The opsonic activity of heat treated serum from patients
had no association with clinical characteristics (i.e. fever,
bloody stools, duration of illness, or age of the patient).
Discussion
Campylobacter concisus, originally associated with the
human oral cavity, has been proposed as an emerging
pathogen causing gastrointestinal disease in humans [13].
C. concisus requires specific hydrogen-enriched micro-
aerobic conditions for growth, probably causing it to be
underreported, since such conditions are not frequently
used in routine clinical laboratories. Furthermore, the
isolation from human faecal specimens is facilitated by
the filter method [14], which may not be in general use
in diagnostic laboratories. To investigate the potential
of this organism to initiate inflammatory disease, we
examined the pathogen-host relationship with use of
neutrophil cells of healthy donors. Firstly the expression
of CD11b on the surface of phagocytes exposed to C.
concisus was measured using flow cytometry. CD11b is
necessary for the adhesion of neutrophils to the vascular
endothelium in response to cytokines released from tissue
invaded by a pathogen. Up-regulation of CD11b on the
surface is one of the first signs of phagocytes responding
Table 3 Neutrophil activation by different isolates of Campylobacter concisus
Strain CD11b up-regulation1 (n=3) Oxidative burst response2 (n=4) Sex/age Clinical characteristic
2010-1718 12.6 (12.4-19.6) 3.0 (2.7-3.9) F/2 Bloody diarrhoea
2012-197540 13.5 (12.6-18.7) 2.5 (2.1-2.9) F/58 Diarrhoea
2009-75775 12.7 (10.4-19.5) 2.4 (2.1-3.6) M/29 Crohn’s disease
2009-119100 15.1 (14.4-19.0) 2.7 (2.0-3.3) F/63 Collagenous colitis
2009-118452 18.0 (12.8-18.9) 3.2 (2.9-4.1) F/19 Crohn’s disease
ATCC 33237 11.9 (11.8-18.1) 2.8 (2.5-3.0) Gingival sulcus
1Ratio between the expression of CD11b on the neutrophil cell surface after exposure to C. concisus compared to the expression when exposed to PBS. 2Ratio
between the neutrophil oxidative burst response when exposed to C. concisus compared to the oxidative burst response when exposed to PBS. Values are
presented as mean (range).
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burst response were carried out both towards C.
concisus opsonised with heat-treated serum from diarrhoeic
C. concisus infected patients, C. concisus opsonised with
heat-treated pooled serum from healthy donors and C.
concisus alone.
Clinically, C. concisus have recently been associated with
prolonged diarrhoea in 80% of patients with culture-
positive C. concisus gastroenteritis, whereas the pathogen
gives rise to an elevated C-reactive protein level only
about half as often as C. jejuni/coli (48% compared to
94%) [6]. These findings could be consistent with an
evasive property in C. concisus towards the immune
system, causing the responsiveness of neutrophils to be
compromised. The observation also suggests that the
pathogenesis of C. concisus associated pathology differs
from the acute mucosal gastroenteritis well described for
C. jejuni/coli. A more superficial mucosal interaction with
C. concisus is likely, and consequently less involvement of
a systemic inflammatory response (C-reactive protein
increase) is to be expected. In this study we found that
neutrophil cells from healthy donors respond to C. concisus
in a dose-dependent manner both when investigating the
expression of CD11b on the cell surface and the outburst
of reactive oxygen intermediates (ROIs). The extracellular
release of toxic oxygen radicals from neutrophils in the
acute inflammation might contribute to the local tissue
damage during infection and potentiate the inflammatory
reaction. Furthermore we showed that although neutrophils
respond towards C. concisus without these being opsonised
with serum the response is increased when bacteria are
opsonised. Previous studies have found that opsonised C.
jejuni generates a higher degree of neutrophil granulocyte
response than non-opsonised bacteria [1,2,15] correlating
well with our findings. Our study design does not allow
us to definitely conclude whether opsonisation induces
increased phagocytosis of C. concisus. Previous investi-
gations of C. jejuni and H. pylori [2-4] have shown that
opsonisation significantly increases phagocytosis in both
complement-dependent and –independent assays. Com-
bination of heat-treated and untreated serum produceda higher opsonic activity for C. jejuni stimulation of
neutrophils [4].
Our findings did not indicate any major differences in
the neutrophil stimulating properties of the six different
C. concisus isolates investigated differing from the results
investigating isolates of C. jejuni [3], where large variations
was reported. In other assays of inflammatory mediators,
however, heterogeneity of C concisus isolates has been
reported [11]. It is possible that various subgroups of C.
concisus exist and preliminary genetic data suggest C
concisus to be a very heterogeneous species. However, for
the five clinical isolates and the oral reference strain we
observed no substantial difference in the responses upon
neutrophil stimulation. It remains to be further examined
if differences in genetic characteristics are translated into
differences in the activation of the innate immune system
of neutrophils. Moreover, it is striking that an oral isolate
exhibited the same activity as the faecal isolates. At this
point it is controversial if oral and faecal strains of C.
concisus are linked or are separate subgroups. Several of
the isolates investigated (75775, 118452, 119100 and 1718)
have in a previous study been shown to have the ability to
perturb the barrier function of HT-29/B6 intestinal epithe-
lial cells [10]. Furthermore, the pathogenic potential of C.
concisus has been demonstrated in models of cellular
invasiveness in human intestinal epithelial cells [16].
Whether or not C. concisus is able to be invasive in the
host is unknown, but no report on bloodstream isolation
of C. concisus has been published. C. concisus opsonised
with serum from C. concisus positive patients did not
generate a larger neutrophil response than those opsonised
with pooled serum from healthy individuals, indicating a
weak IgG response towards the bacteria. However, we
cannot exclude that the sensitivity of the assay employed in
the present study does not allow to detect specific IgG
activity. Previously, another mucosal gastroenteric pathogen,
Helicobacter pylori, was reported to be opsonised equally
well with sera from infected patients and healthy controls
[17]. So far, no assay of serum immunoglobulin concentra-
tion specifically for C. concisus has been reported, so the
magnitude of systemic antibody response is unclear.
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Human neutrophil cells show an innate immune reaction
towards C. concisus even at low concentrations at both the
initiation of the immune-inflammatory response with up-
regulation of the adherence molecule CD11b as well as
later in the response with the outburst of reactive oxygen
radicals. The latter increases when the pathogen is opsonised
with serum, but we did not observe immunoglobulin asso-
ciated amplification of the response in heat treated serum
from patients with C. concisus infection. The findings of
pro-inflammatory activation in neutrophils support the po-
tential and clinical relevance of C. concisus as an emerging
enteric pathogen. The outcome of C. concisus associated
diarrhoea is very diverse and it remains to be investigated
if the responses of the innate immune system correlate
with the clinical presentation.
Methods
Isolates of campylobacter concisus
Five faecal isolates from diarrheic patients were selected for
the study (C. concisus isolates 2010–1718, 2009–75775,
2009–118452, 2009–119100, and 2012–197540 as previ-
ously published [18]) as well as the oral reference strain
C. concisus ATCC 33237). Isolates were cultured on 5%
horse blood agar, containing 1% yeast extract (SSI
Diagnostica, Hillerød, Denmark), and incubated at 37°C
in a microaerobic atmosphere with 3% hydrogen. Final
confirmation was obtained through a species-specificFigure 3 Forward-side scatter dot plot of unstimulated neutrophils (A
monocytes (B) as well as histograms of CD11b up-regulation in unstim
concisus isolate 2010–1718 at the ratio 7.5:1.real-time PCR based on the cpn60 gene, as described by
Chaban et al. [19]. After two days bacterial cells were
suspended in phosphate buffered saline (PBS) to a concen-
tration of approximately 75 × 106 CFU/ml (absorbance
0.25 McFarland units) and transferred to 2 ml aliquots
that were stored at −20°C until use.Measurement of optical density
To ensure that the concentration of the six different C.
concisus isolates were the same throughout the experi-
ments, measurements of optical density were carried out
using Spectramax (Molecular Devices, LLC, USA) at a
wavelength of 600 nm and converted to concentration
using a linear model made from a series of measurements
of the isolate 2010–1718.Isolation of neutrophil granulocytes
Peripheral venous blood was taken from healthy adult
donors, anticoagulated by EDTA and separated by
centrifugation (500 g for 30 minutes) on polymorphprep
(Axis-Shield, Dundee, Scotland). Neutrophils were washed
three times in PBS-AG (100 ml PBS, 0.1g albumin,
0.2 ml 50%glucose), and the final neutrophil cell con-
centration was adjusted to 2 × 106 cells/ml suspended
in PBS-AG using sysmex xs-1000i (Sysmex Corporation,
Kobe, Japan).), side scatter dot plot with anti-CD14 identification of
ulated (C) and stimulated (D) neutrophils stimulated with C.
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Serum samples were taken from 40 diarrheic patients
with culture-positive C. concisus stool samples approxi-
mately 4 weeks after the diagnosis had been made [6].
For the pooled serum used for controls, serum samples
from five healthy male donors were used. Serum was
transferred to cryovials and stored at −80°C until use.
Before use serum samples were heat treated at 56°C for
30 minutes to inactivate the complement system and
then diluted to 1:200 with PBS. In prior experiments this
concentration was found to be optimal for the oxidative
burst response assay (data not shown).
Adherence molecule expression assay
Flow cytometry was used to quantify the expression of
CD11b on neutrophils exposed to six different isolates
of C. concisus. Each isolate of C. concisus was diluted to
concentrations of 0.75, 7.5 and 75 times the average
concentration of neutrophils (5x106/ml) before being
added to heparinised whole blood from a healthy adult
donor in the ratio 1:1. The samples were incubated for
30 minutes at 37°C. Unstimulated controls were run in
parallel. Immediately after incubation the samples were
cooled on ice and 10 μl of anti-CD11b (APC-marked,
Becton, Dickinson and Co., New Jersey, USA) and anti-
CD14 (Fitc marked; Dako, Glostrup, Denmark) antibodies
were added. Anti-CD14 antibodies were used to identify
the monocyte population in the samples. To one sample
of each isolate 10 μl of isotype control for Fitc and APC
(isotype Fitc/APC/PE antibodies, Dako) were added. After
an incubation time of 45 minutes at 5°C erythrocytes were
lysed using lysing solution (Becton, Dickinson and Co.),
the leukocytes were washed in PBS and suspended in
sheath fluid (Becton, Dickinson and Co.) [20,21] and the
samples run using a FACScanto fluorescence flow
cytometer (Becton, Dickinson and Co.). The results were
analysed using FACSDiva software (Becton, Dickinson
and Co.). A forward/side scatter dot plot correlated with a
forward scatter/anti-CD14 dot plot was used to identify
neutrophils and exclude monocytes (Figure 3). The expres-
sion of CD11b was analysed using a histogram of the
region containing neutrophils. Results are presented as a
ratio between mean fluorescence intensity and the mean
value of unstimulated cells.
Oxidative burst response assay
Luminol dependent chemiluminiscence was used to
measure the oxidative burst response of neutrophils against
C. concisus isolate 2010–1718 opsonised with heat treated
patient serum and heat treated pooled donor serum,
respectively. For each serum sample a negative control with
PBS was run in parallel. All samples were run as duplicates
and on every plate a control without serum was run in
parallel. Forty patient samples were run three times eachwith 2–3 patient samples per plate. Each plate contained a
control with pooled serum and neutrophils from a healthy
donor. In total 54 plates were run. 100 μl luminol, 25 μl
heat-treated serum, 50 μl neutrophil cells (2 × 106 cells/ml)
and 100 μl bacterial suspension or PBS was added to the
wells of a white polysorb microtiter plate and run immedi-
ately in at 37°C using Lumistar (BMG Labtech, Ortenberg,
Germany). The peak value was reached after approximately
30minutes and each experiment ran for at least 40 minutes.
Peak luminescence values were corrected by subtracting
the peak value of unstimulated cells.
When comparing the neutrophil reaction towards differ-
ent C. concisus isolates the test was run simultaneously for
all strains with neutrophils from the same donor and
heat-treated pooled serum using the same quantities as
mentioned above. All samples were run in duplicates. The
results are presented as ratios between the peak lumines-
cence value and the value of unstimulated cells.
Statistical analysis
Statistical analysis was carried out using probit plots and
the student’s t-test for normally distributed data and the
Wilcoxon-test for non-normally distributed data.
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